Research Highlights

Since its inception, the Vancouver Prostate Centre’s research activities have led to valuable new insights, treatments, and intellectual property:

  • We were instrumental in establishing the use of Intermittent Androgen Ablation Therapy as a standard treatment modality for prostate cancer
  • In 2015, the Centre developed a potential new therapeutic that is designed to outsmart cancer and inhibit tumour growth by disabling the androgen receptor where it binds to a specific part of the DNA that is not prone to mutation, opening the possibility of designing drugs that could be effective for a long time
    • The drug candidate was developed using computer-aided drug design (CADD), a technology that evaluates a database of millions of different molecules to identify a handful which may work well as possible treatments
  • My Precision Oncology Program (MyPOP), made possible by infrastructural investment from the Canadian Foundation for Innovation and a generous donation by a private donor, allows for the routine linking of genomic sequencing data with real-time clinical decision making
  • Our annual knowledge output averages 120 peer-reviewed publications and 150 presentations at conferences
  • Since 2008, our Centre has been awarded over $125 million in peer-reviewed research grants from regional, national and international agencies
  • Since 2008 we have initiated 138 new Clinical Trials enrolling 2,886 patients
  • We have a strong record of recruitment of senior staff and faculty promotions
  • The Centre currently had 37 post-doctoral fellows, 35 Ph.D. students and 13 Masters students
  • Since 2008 we have negotiated 56 new contract research agreements with pharmaceutical and biotech companies including Pfizer, Takeda, AstraZeneca, Bayer and Janssen
  • Intellectual Property Activities since 2008 include
    •  294 patent filed/issued
    •  9 Licensing Agreements of IP with Industry (8 drug, 1 biomarker)
      • Our 2015 licensing to Roche was UBC's largest out-licensing deal to date
  • Discoveries at our Centre have led to the creation of several biotech companies, including OncoGeneX (now Achieve Life Sciences) and Aquinox

 

Page updated November 1, 2018

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Plaid for Dad

Plaid for Dad Fundraiser, June 14, 2019

Plaid for Dad is a workplace fundraiser for Prostate Cancer Canada, with online registration & fundraising leading up to Friday June 14th's "wear plaid to work" day. Visit the event website to register a team, join/fundraise for a team or buy plaid to wear on the day.      

Fathers Day Walk Run 2019

Raymond James Father's Day Walk Run Fundraiser, June 16, 2019

The 21st Annual Raymond James Walk Run fundraiser for Prostate Cancer Foundation BC takes place on Sunday June 16, 2019 in various locations across BC. Registration fees ($40) include a shirt and BBQ lunch, and are waived for those who raise over $150. Click here to sponsor our Centre's team (opens in new window).

 

Employment

Work at the Vancouver Prostate Centre

Friday, May 3, 2019

Dr. Mads Daugaard receives the St. Baldrick’s Foundation Robert J. Arceci Innovation Award

Dr. Daugaard
Thursday, April 18, 2019

Dr. Subramaniam joins UBC as Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design

Dr. Subramaniam
Monday, April 1, 2019

VPC's translational research profiled in UBC Faculty of Medicine News

Dr. Gleave at the VPC